Levmetamfetamine

Levmetamfetamine

SCHEMBL42099

CN[C@H](C)Cc1ccccc1.Cl

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Levmetamfetamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.57
SIGMAR1 Q99720 7/20 0.95
TAAR1 Q96RJ0 3/20 0.95
SLC18A2 Q05940 1/20 0.95
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
TSHR P16473 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methamphetamine SCHEMBL9114797 1.00 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL1608168 1.00 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42098 1.00 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42100 1.00 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Levmetamfetamine SCHEMBL9114800 1.00 SIGMAR1 (0.95) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL13747483 0.98 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL15094315 0.98 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL20211416 0.98 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42615 0.98 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Levmetamfetamine SCHEMBL727412 0.98 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3135 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122055143-A Solid compositions containing bromhexine 第一三共健康事业株式会社 2026-05-15 CN claimed
US-12436136-B2 Device for the detection of conditions indicative of illicit drug production P ALERT LIMITED (NZ) 2025-10-07 US claimed
US-12257283-B2 Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof CREATIVE BIO-PEPTIDES, INC. (US) 2025-03-25 US claimed
CN-119023646-A Fingerprint reproduction device and reproduction method based on surface enhanced Raman substrate 电子科技大学 2024-11-26 CN claimed
CN-118362674-B Feature spectrum of Kemin capsule and content detection method of various quality markers 山东省中医药研究院 2024-10-01 CN claimed
CN-118362674-A Feature spectrum of Kemin capsule and content detection method of various quality markers 山东省中医药研究院 2024-07-19 CN claimed
US-20240201155-A1 Device for the Detection of Conditions Indicative of Illicit Drug Production P ALERT LIMITED (NZ) 2024-06-20 US claimed
CN-115980330-A Fluorescent quantitative card for rapidly detecting 9 drugs and preparation method and application thereof 江苏安科华捷生物科技有限公司 2023-04-18 CN claimed
US-20230062853-A1 Methods and Compositions for Use of a Chemokine Receptor Antagonist Peptide to Treat Addiction, Substance Abuse Disorders or Symptoms Thereof CREATIVE BIO-PEPTIDES, INC. 2023-03-02 US claimed
CN-115252814-A Cyclodextrin-metal organic framework composition and preparation method thereof 中国科学院上海药物研究所 2022-11-01 CN claimed
CN-1230416-A Combined application of pineal body, bezoar, date kernel, Radix Angelica Dahurica and Rhizoma corydalis in treating medicament dependence disease TAO RAN (CN) 1999-10-06 CN claimed
EP-0935523-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GENERAL MILLS, INC. (US) 1999-08-18 EP claimed
EP-0344675-B2 Method for the production of selegiline hydrochloride FARMAK A S (CS) 1998-11-11 EP claimed
US-5811547-A Method for inducing crystalline state transition in medicinal substance NIPPON SHINYAJU CO., LTD. (JP) 1998-09-22 US claimed
WO-1998018610-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES LENGERICH BERNHARD H VAN (US) 1998-05-07 WO claimed
US-5023088-A Drug delivery dispenser ALZA CORPORATION (US) 1991-06-11 US claimed
EP-0169057-B1 METHOD AND APPARATUS FOR DETECTING A CONTRABAND SUBSTANCE BRITISH AEROSPACE PUBLIC LIMITED COMPANY (GB) 1991-05-08 EP claimed
US-4718268-A Method and apparatus for detecting a contraband substance BRITISH AEROSPACE PUBLIC LIMITED COMPANY (GB) 1988-01-12 US claimed
EP-0169057-A2 Method and apparatus for detecting a contraband substance BRITISH AEROSPACE PUBLIC LIMITED COMPANY (GB) 1986-01-22 EP claimed
US-3968245-A Sympathomimetic topical and percutaneous administration with halogenated promoters ALZA CORPORATION (US) 1976-07-06 US claimed